Ventrus Biosciences Balance Sheet - Annual (NASDAQ:ASMB)

Add to My Stocks
$36.1 $0.69 (1.88%) ASMB stock closing price Sep 21, 2018 (Closing)

The financial analysis of a company like Ventrus Biosciences involves checking the three financial statements of the company in detail, of which the balance sheet is one. Balance sheet items like cash at hand, total assets and liabilities helps one analyze a company and summarize the financial performance of the company like we have in our Ventrus Biosciences stock analysis. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. Ventrus Biosciences had a long term debt of $- at the end of 2017. To understand the debt servicing capacity of the company, one needs to look at Ventrus Biosciences operating cash flow and Ventrus Biosciences revenue also. Ventrus Biosciences debt to equity ratio is 0.

View latest 10 year balance sheet data to check Ventrus Biosciences financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012201120102009
Cash82.03M28.57M27.1M29.09M27.06M20.48M36.97M14.57M-
Marketable Securities37.91M24.38M40.55M------
Receivables2.27M--------
Inventory---------
Raw Materials---------
Work In Progress---------
Finished Goods---------
Notes Receivable---------
Other Current Assets---------
Total Current Assets
123.11M53.57M68.36M29.21M27.12M20.54M37.03M14.58M-
Property Plant & Equipment1.27M--------
Accumulated Depreciation---------
Net Property Plant & Equipment
---------
Investment & Advances3.34M2.43M23.39M------
Other Non-Current Assets---------
Deferred Charges---------
Intangibles41.63M41.63M41.63M41.73M-----
Deposits & Other Assets---------
Total Assets
169.3M98.11M133.74M71.22M27.13M20.55M37.04M14.61M-
Notes Payable---------
Accounts Payable2.12M2.36M1.36M-2.61M1.84M2.34M--
Current Portion Long-Term Debt-------1.21M-
Current Portion Capital Leases---------
Accrued Expenses6.13M4.75M2.03M------
Income Taxes Payable---------
Other Current Liabilities5.22M--------
Total Current Liabilities
13.49M7.12M3.4M1.05M2.63M2.74M2.51M1.71M-
Mortgages---------
Deferred Taxes/Income42.69M11.11M11.6M11.6M-----
Convertible Debt---------
Long-Term Debt-------1.27M-
Non-Current Capital Leases---------
Other Long-Term Liabilities---------
Total Liabilities
56.18M18.24M15M12.65M2.63M2.74M2.51M2.99M-
Minority Interest---------
Preferred Stock---------
Common Stock Net---------
Capital Surplus364.52M288.68M283.51M194.07M135.82M110.11M102.04M44.8M-
Retained Earnings-251.03M-208.22M-163.96M-135.51M-111.72M-92.31M-67.52M-33.18M-
Treasury Stock---------
Other Liabilities-0.39M-0.6M-0.82M------
Shareholders Equity113.11M79.87M118.74M58.57M24.49M17.81M34.53M11.62M-
Total Liabilities & Shareholders Equity169.3M98.11M133.74M71.22M27.13M20.55M37.04M14.61M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Looking at Ventrus Biosciences historical stock prices and the current Ventrus Biosciences stock price can tell you how the stock price has moved, whereas the Ventrus Biosciences PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like Ventrus Biosciences owns and has economic value. The two major types of assets are: fixed assets like real estate, plant and machinery and current assets like cash, marketable securities and inventory. The total asset value for ASMB stock as of 2017 is $169.3M. Its easy to associate the term with manufacturing companies, which invest a lot in factories and equipment. However, the same cannot be said about tech stocks.
  • Liabilities: The total liabilities of Ventrus Biosciences for the year 2017 total to $56.18M. Liabilities for a company like Ventrus Biosciences include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Ventrus Biosciences Balance Sheet - Key Ratios

Current ratio
7.43
Debt to equity ratio
0
Asset turnover ratio
0.09
Receivables turnover
6.96
Price to book ratio
9.08